ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets

RTTNews | 916 days ago
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.

ANI's Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.

The current annual U.S. market for Clorazepate Dipotassium Tablets is approximately $25.8 million, according to IQVIA/IMS Health, a leading healthcare data and analytics provider.

read more
Bay Street Likely To Open Slightly Higher

Bay Street Likely To Open Slightly Higher

Canadian shares are likely to open higher on Tuesday, and trading may be a bit lackluster and volumes rather thin as the market will close at 1 pm, and remain closed on Wednesday and Thursday for Christmas and Boxing Day holidays.
RTTNews | 8h 53min ago